Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function
- Autores
- Cerda Troncoso, Cristóbal; Grünenwald, Felipe; Arias Muñoz, Eloísa; Cavieres, Viviana A.; Caceres Verschae, Albano; Hernández, Sergio; Gaete Ramírez, Belén; Álvarez Astudillo, Francisca; Acuña, Rodrigo A.; Ostrowski, Matias; Burgos, Patricia V.; Varas Godoy, Manuel
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Chemoresistance is a common problem in ovarian cancer (OvCa) treatment, where resistant cells, in response to chemotherapy, secrete small extracellular vesicles (sEVs), known as chemo-sEVs, that transfer resistance to recipient cells. sEVs are formed as intraluminal vesicles (ILVs) within multivesicular endosomes (MVEs), whose trafficking is regulated by Ras-associated binding (RAB) GTPases that mediate sEVs secretion or lysosomal degradation. A decrease in lysosomal function can promote sEVs secretion, but the relationship between MVEs trafficking pathways and sEVs secretion in OvCa chemoresistance is unclear. Here, we show that A2780cis cisplatin (CCDP) resistant OvCa cells had an increased number of MVEs and ILVs structures, higher levels of Endosomal Sorting Complex Required for Transport (ESCRTs) machinery components, and RAB27A compared to A2780 CDDP-sensitive OvCa cells. CDDP promoted the secretion of chemo-sEVs in A2780cis cells, enriched in DNA damage response proteins. A2780cis cells exhibited poor lysosomal function with reduced levels of RAB7, essential in MVEs-Lysosomal trafficking. The silencing of RAB27A in A2780cis cells prevents the Chemo-EVs secretion, reduces its chemoresistance and restores lysosomal function and levels of RAB7, switching them into an A2780-like cellular phenotype. Enhancing lysosomal function with rapamycin reduced chemo-sEVs secretion. Our results suggest that adjusting the balance between secretory MVEs and lysosomal MVEs trafficking could be a promising strategy for overcoming CDDP chemoresistance in OvCa.
Fil: Cerda Troncoso, Cristóbal. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile
Fil: Grünenwald, Felipe. Universidad San Sebastián; Chile
Fil: Arias Muñoz, Eloísa. Universidad San Sebastián; Chile
Fil: Cavieres, Viviana A.. Universidad San Sebastián; Chile
Fil: Caceres Verschae, Albano. Universidad San Sebastián; Chile
Fil: Hernández, Sergio. Universidad San Sebastián; Chile
Fil: Gaete Ramírez, Belén. Universidad San Sebastián; Chile
Fil: Álvarez Astudillo, Francisca. Universidad San Sebastián; Chile
Fil: Acuña, Rodrigo A.. Universidad del Desarrollo; Chile
Fil: Ostrowski, Matias. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina
Fil: Burgos, Patricia V.. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile
Fil: Varas Godoy, Manuel. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile. Advanced Center for Chronic Diseases; Chile - Materia
-
Vesiculas Extracelulares
Cancer de ovario
Quimioresistencia
Rab27 - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/266188
Ver los metadatos del registro completo
id |
CONICETDig_570c8966f4ea07a96247970b5ffab6ed |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/266188 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal functionCerda Troncoso, CristóbalGrünenwald, FelipeArias Muñoz, EloísaCavieres, Viviana A.Caceres Verschae, AlbanoHernández, SergioGaete Ramírez, BelénÁlvarez Astudillo, FranciscaAcuña, Rodrigo A.Ostrowski, MatiasBurgos, Patricia V.Varas Godoy, ManuelVesiculas ExtracelularesCancer de ovarioQuimioresistenciaRab27https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Chemoresistance is a common problem in ovarian cancer (OvCa) treatment, where resistant cells, in response to chemotherapy, secrete small extracellular vesicles (sEVs), known as chemo-sEVs, that transfer resistance to recipient cells. sEVs are formed as intraluminal vesicles (ILVs) within multivesicular endosomes (MVEs), whose trafficking is regulated by Ras-associated binding (RAB) GTPases that mediate sEVs secretion or lysosomal degradation. A decrease in lysosomal function can promote sEVs secretion, but the relationship between MVEs trafficking pathways and sEVs secretion in OvCa chemoresistance is unclear. Here, we show that A2780cis cisplatin (CCDP) resistant OvCa cells had an increased number of MVEs and ILVs structures, higher levels of Endosomal Sorting Complex Required for Transport (ESCRTs) machinery components, and RAB27A compared to A2780 CDDP-sensitive OvCa cells. CDDP promoted the secretion of chemo-sEVs in A2780cis cells, enriched in DNA damage response proteins. A2780cis cells exhibited poor lysosomal function with reduced levels of RAB7, essential in MVEs-Lysosomal trafficking. The silencing of RAB27A in A2780cis cells prevents the Chemo-EVs secretion, reduces its chemoresistance and restores lysosomal function and levels of RAB7, switching them into an A2780-like cellular phenotype. Enhancing lysosomal function with rapamycin reduced chemo-sEVs secretion. Our results suggest that adjusting the balance between secretory MVEs and lysosomal MVEs trafficking could be a promising strategy for overcoming CDDP chemoresistance in OvCa.Fil: Cerda Troncoso, Cristóbal. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; ChileFil: Grünenwald, Felipe. Universidad San Sebastián; ChileFil: Arias Muñoz, Eloísa. Universidad San Sebastián; ChileFil: Cavieres, Viviana A.. Universidad San Sebastián; ChileFil: Caceres Verschae, Albano. Universidad San Sebastián; ChileFil: Hernández, Sergio. Universidad San Sebastián; ChileFil: Gaete Ramírez, Belén. Universidad San Sebastián; ChileFil: Álvarez Astudillo, Francisca. Universidad San Sebastián; ChileFil: Acuña, Rodrigo A.. Universidad del Desarrollo; ChileFil: Ostrowski, Matias. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; ArgentinaFil: Burgos, Patricia V.. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; ChileFil: Varas Godoy, Manuel. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile. Advanced Center for Chronic Diseases; ChileWiley Blackwell Publishing, Inc2024-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/266188Cerda Troncoso, Cristóbal; Grünenwald, Felipe; Arias Muñoz, Eloísa; Cavieres, Viviana A.; Caceres Verschae, Albano; et al.; Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function; Wiley Blackwell Publishing, Inc; Journal of Extracellular Biology; 3; 6; 5-2024; 1-262768-2811CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://isevjournals.onlinelibrary.wiley.com/doi/10.1002/jex2.157info:eu-repo/semantics/altIdentifier/doi/10.1002/jex2.157info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:26:35Zoai:ri.conicet.gov.ar:11336/266188instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:26:36.23CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
title |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
spellingShingle |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function Cerda Troncoso, Cristóbal Vesiculas Extracelulares Cancer de ovario Quimioresistencia Rab27 |
title_short |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
title_full |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
title_fullStr |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
title_full_unstemmed |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
title_sort |
Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function |
dc.creator.none.fl_str_mv |
Cerda Troncoso, Cristóbal Grünenwald, Felipe Arias Muñoz, Eloísa Cavieres, Viviana A. Caceres Verschae, Albano Hernández, Sergio Gaete Ramírez, Belén Álvarez Astudillo, Francisca Acuña, Rodrigo A. Ostrowski, Matias Burgos, Patricia V. Varas Godoy, Manuel |
author |
Cerda Troncoso, Cristóbal |
author_facet |
Cerda Troncoso, Cristóbal Grünenwald, Felipe Arias Muñoz, Eloísa Cavieres, Viviana A. Caceres Verschae, Albano Hernández, Sergio Gaete Ramírez, Belén Álvarez Astudillo, Francisca Acuña, Rodrigo A. Ostrowski, Matias Burgos, Patricia V. Varas Godoy, Manuel |
author_role |
author |
author2 |
Grünenwald, Felipe Arias Muñoz, Eloísa Cavieres, Viviana A. Caceres Verschae, Albano Hernández, Sergio Gaete Ramírez, Belén Álvarez Astudillo, Francisca Acuña, Rodrigo A. Ostrowski, Matias Burgos, Patricia V. Varas Godoy, Manuel |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Vesiculas Extracelulares Cancer de ovario Quimioresistencia Rab27 |
topic |
Vesiculas Extracelulares Cancer de ovario Quimioresistencia Rab27 |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Chemoresistance is a common problem in ovarian cancer (OvCa) treatment, where resistant cells, in response to chemotherapy, secrete small extracellular vesicles (sEVs), known as chemo-sEVs, that transfer resistance to recipient cells. sEVs are formed as intraluminal vesicles (ILVs) within multivesicular endosomes (MVEs), whose trafficking is regulated by Ras-associated binding (RAB) GTPases that mediate sEVs secretion or lysosomal degradation. A decrease in lysosomal function can promote sEVs secretion, but the relationship between MVEs trafficking pathways and sEVs secretion in OvCa chemoresistance is unclear. Here, we show that A2780cis cisplatin (CCDP) resistant OvCa cells had an increased number of MVEs and ILVs structures, higher levels of Endosomal Sorting Complex Required for Transport (ESCRTs) machinery components, and RAB27A compared to A2780 CDDP-sensitive OvCa cells. CDDP promoted the secretion of chemo-sEVs in A2780cis cells, enriched in DNA damage response proteins. A2780cis cells exhibited poor lysosomal function with reduced levels of RAB7, essential in MVEs-Lysosomal trafficking. The silencing of RAB27A in A2780cis cells prevents the Chemo-EVs secretion, reduces its chemoresistance and restores lysosomal function and levels of RAB7, switching them into an A2780-like cellular phenotype. Enhancing lysosomal function with rapamycin reduced chemo-sEVs secretion. Our results suggest that adjusting the balance between secretory MVEs and lysosomal MVEs trafficking could be a promising strategy for overcoming CDDP chemoresistance in OvCa. Fil: Cerda Troncoso, Cristóbal. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile Fil: Grünenwald, Felipe. Universidad San Sebastián; Chile Fil: Arias Muñoz, Eloísa. Universidad San Sebastián; Chile Fil: Cavieres, Viviana A.. Universidad San Sebastián; Chile Fil: Caceres Verschae, Albano. Universidad San Sebastián; Chile Fil: Hernández, Sergio. Universidad San Sebastián; Chile Fil: Gaete Ramírez, Belén. Universidad San Sebastián; Chile Fil: Álvarez Astudillo, Francisca. Universidad San Sebastián; Chile Fil: Acuña, Rodrigo A.. Universidad del Desarrollo; Chile Fil: Ostrowski, Matias. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Biomédicas en Retrovirus y Sida; Argentina Fil: Burgos, Patricia V.. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile Fil: Varas Godoy, Manuel. Universidad San Sebastián; Chile. Fundación Ciencia & Vida; Chile. Advanced Center for Chronic Diseases; Chile |
description |
Chemoresistance is a common problem in ovarian cancer (OvCa) treatment, where resistant cells, in response to chemotherapy, secrete small extracellular vesicles (sEVs), known as chemo-sEVs, that transfer resistance to recipient cells. sEVs are formed as intraluminal vesicles (ILVs) within multivesicular endosomes (MVEs), whose trafficking is regulated by Ras-associated binding (RAB) GTPases that mediate sEVs secretion or lysosomal degradation. A decrease in lysosomal function can promote sEVs secretion, but the relationship between MVEs trafficking pathways and sEVs secretion in OvCa chemoresistance is unclear. Here, we show that A2780cis cisplatin (CCDP) resistant OvCa cells had an increased number of MVEs and ILVs structures, higher levels of Endosomal Sorting Complex Required for Transport (ESCRTs) machinery components, and RAB27A compared to A2780 CDDP-sensitive OvCa cells. CDDP promoted the secretion of chemo-sEVs in A2780cis cells, enriched in DNA damage response proteins. A2780cis cells exhibited poor lysosomal function with reduced levels of RAB7, essential in MVEs-Lysosomal trafficking. The silencing of RAB27A in A2780cis cells prevents the Chemo-EVs secretion, reduces its chemoresistance and restores lysosomal function and levels of RAB7, switching them into an A2780-like cellular phenotype. Enhancing lysosomal function with rapamycin reduced chemo-sEVs secretion. Our results suggest that adjusting the balance between secretory MVEs and lysosomal MVEs trafficking could be a promising strategy for overcoming CDDP chemoresistance in OvCa. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/266188 Cerda Troncoso, Cristóbal; Grünenwald, Felipe; Arias Muñoz, Eloísa; Cavieres, Viviana A.; Caceres Verschae, Albano; et al.; Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function; Wiley Blackwell Publishing, Inc; Journal of Extracellular Biology; 3; 6; 5-2024; 1-26 2768-2811 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/266188 |
identifier_str_mv |
Cerda Troncoso, Cristóbal; Grünenwald, Felipe; Arias Muñoz, Eloísa; Cavieres, Viviana A.; Caceres Verschae, Albano; et al.; Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function; Wiley Blackwell Publishing, Inc; Journal of Extracellular Biology; 3; 6; 5-2024; 1-26 2768-2811 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://isevjournals.onlinelibrary.wiley.com/doi/10.1002/jex2.157 info:eu-repo/semantics/altIdentifier/doi/10.1002/jex2.157 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614267372830720 |
score |
13.070432 |